Monivent AB (XSAT:MONI) Common Stock : kr8.07 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Monivent AB Common Stock?

Monivent AB's quarterly common stock stayed the same from Sep. 2023 (kr2.71 Mil) to Dec. 2023 (kr2.71 Mil) but then increased from Dec. 2023 (kr2.71 Mil) to Mar. 2024 (kr8.07 Mil).

Monivent AB's annual common stock increased from Dec. 2021 (kr1.90 Mil) to Dec. 2022 (kr2.55 Mil) and increased from Dec. 2022 (kr2.55 Mil) to Dec. 2023 (kr2.71 Mil).

Monivent AB Common Stock Historical Data

The historical data trend for Monivent AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monivent AB Common Stock Chart

Monivent AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.66

1.67

1.90

2.55

2.71

Monivent AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															2.55	2.55	2.71	2.71	8.07

Monivent AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Monivent AB (XSAT:MONI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monivent AB (XSAT:MONI) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55

Website

https://www.monivent.se

Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.